...is in Phase II trials to treat COPD and atopic dermatitis. JMT-BIO is a subsidiary of CSPC Pharmaceutical Group Ltd....
...MK-8591) insitro Inc. Canbridge Pharmaceuticals Inc. Aveo Pharmaceuticals Inc. Gilead Sciences Inc. Merck & Co. Inc. Cell and Gene Therapy Catapult GlaxoSmithKline plc CSPC Pharmaceutical Group Ltd....

...the NRDL with greater than RMB1 billion in annual sales, including stroke therapies butylphthalide from CSPC Pharmaceutical Group Ltd....

...as well as existing investors BioTrack Capital, Yingke PE, Atlas Venture and entities associated with CSPC Pharmaceutical Group Ltd....

...pricing pressure particularly to long-covered drugs with limited competition such as stroke therapy butylphthalide from CSPC Pharmaceutical Group Ltd....

...remediation efforts. Morgan Stanley’s Yolandu Hu said that Jiangsu Hengrui Medicine Co. Ltd. (Shanghai:600276) and CSPC Pharmaceutical Group Ltd....

...lymphoma. The anti-CD19 antibody has breakthrough therapy designation. Junshi, CSPC end deal for PD-1 blocker CSPC Pharmaceutical Group Ltd....
...terms were not disclosed. BioCentury Staff Tuoyi, toripalimab (JS001) tislelizumab (BGB-A317) Solasia Pharma K.K. EditForce Inc. BeiGene Ltd. Shanghai Junshi Biosciences Co. Ltd. CSPC Pharmaceutical Group Ltd. Programmed...

...companies. HaiHe narrowed its focus to oncology in February when it formed a JV with CSPC Pharmaceutical Group Ltd....

...drugs could benefit from the revision, with possible inclusion of drugs from 3SBio Inc. (HKSE:1530), CSPC Pharmaceutical Group Ltd....
...HK$14.60 and Hengrui gained RMB0.07 to RMB69.88. CSPC fell HK$0.32 to HK$13.32. Hongjiang Li, Staff Writer 3SBio Inc. CSPC Pharmaceutical Group Ltd. Innovent...

...Shanghai HaiHe Biopharma Co. Ltd. (Shanghai, China) formed a joint venture with CSPC Pharmaceutical Group Ltd. (HKSE:1093) to develop...
...receptor Shanghai HaiHe Biopharma Co. Ltd., Shanghai, China CSPC Pharmaceutical Group Ltd. (HKSE:1093), Hong Kong, China Business: Other Hongjiang Li CSPC Pharmaceutical Group Ltd. Haihe...

...Shanghai HaiHe Biopharma Co. Ltd. (Shanghai, China) formed a joint venture with CSPC Pharmaceutical Group Ltd. (HKSE:1093) to develop...
...kinase; COX-2 - Cyclooxygenase-2; FGFR - Fibroblast growth factor receptor; PTGER4 - Prostanoid EP4 receptor Hongjiang Li CSPC Pharmaceutical Group Ltd. Haihe...